ITeos Therapeutics Inc’s filing revealed that its Chief Executive Officer Detheux Michel unloaded Company’s shares for reported $0.44 million on Jun 09 ’25. In the deal valued at $10.03 per share,43,882 shares were sold. As a result of this transaction, Detheux Michel now holds 0 shares worth roughly $0.0.
Then, Detheux Michel sold 43,883 shares, generating $439,708 in total proceeds. Upon selling the shares at $10.02, the Chief Executive Officer now owns 0 shares.
Before that, Detheux Michel sold 8,400 shares. ITeos Therapeutics Inc shares valued at $84,252 were divested by the Chief Executive Officer at a price of $10.03 per share. As a result of the transaction, Detheux Michel now holds 135,903 shares, worth roughly $1.37 million.
Wells Fargo downgraded its ITeos Therapeutics Inc [ITOS] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Wedbush’s analysts, who decreased its forecast for the stock in late May from “an Outperform” to “a Neutral”. Leerink Partners also remained covering ITOS and has decreased its forecast on May 14, 2025 with a “Market perform” recommendation from previously “an Outperform” rating. H.C. Wainwright revised its rating on May 14, 2025. It rated ITOS as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ITOS
On Friday, ITeos Therapeutics Inc [NASDAQ:ITOS] saw its stock fall -0.20% to $10.11. Over the last five days, the stock has gained 0.20%. ITeos Therapeutics Inc shares have fallen nearly -35.23% since the year began. Nevertheless, the stocks have risen 31.64% over the past one year.
How much short interest is there in ITeos Therapeutics Inc?
A steep rise in short interest was recorded in ITeos Therapeutics Inc stocks on 2025-07-15, growing by 0.37 million shares to a total of 3.07 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 2.7 million shares. There was a rise of 12.01%, which implies that there is a positive sentiment for the stock.
